To expand the scope of meta-functionalization, a pyrimidine-based template effective for the formation of β-aryl aldehydes and ketones, using allyl alcohols, by meta-C-H activation of benzylsulfonyl esters is described. In addition, α,β-unsaturated aldehydes were generated by in situ olefination and deprotection of allyl benzyl ethers. These new functionalizations at the meta-position of an arene have also been successfully implemented in benzylphosphonate, phenethyl carbonyl, and phenethylsulfonyl ester scaffolds. Key to these successful new functionalizations is the creation of an electropositive palladium center by accepting the electron cloud from the metal to the energetically low-lying π-orbitals of pyrimidine ring, and it favors coordination of allyl alcohol to the metal center.
Chiral α-substituted allylboronic
acids were synthesized
by asymmetric homologation of alkenylboronic acids using CF
3
/TMS-diazomethanes in the presence of BINOL catalyst and ethanol.
The chiral α-substituted allylboronic acids were reacted with
aldehydes or oxidized to alcohols in situ with a high degree of chirality
transfer. The oxygen-sensitive allylboronic acids can be purified
via their isolated diaminonaphthalene (DanH)-protected derivatives.
The highly reactive purified allylboronic acids reacted in a self-catalyzed
reaction at room temperature with ketones, imines, and indoles to
give congested trifluoromethylated homoallylic alcohols/amines with
up to three contiguous stereocenters.
An easily removable pyrimidine-based auxiliary has been employed for the remote meta-C-H cyanation of arenes. The scope of this Pd-catalyzed cyanation reaction using copper(I) cyanide as the cyanating agent was demonstrated with benzylsilanes, benzylsulfonates, benzylphophonates, phenethylsulfonates, and phenethyl ether derivatives. The method was utilized for the synthesis of pharmaceutically valuable precursors.
Arenes containing conformationally flexible long alkyl chains have been successfully functionalized at the meta-position. Good to excellent meta selectivity is achieved for systems with up to 20 atoms between the target C-H bond and the coordinating heteroatom of the directing group. The palladium-catalyzed functionalization reactions include alkylation, cyanation, olefination, and acetoxylation. The meta selectivity is exclusively governed by the design of flexible pyrimidine-based scaffolds.
Controlling
remote
selectivity and delivering novel functionalities
at distal positions in arenes are an important endeavor in contemporary
organic synthesis. In this vein, template engineering and mechanistic
understanding of new functionalization strategies are essential for
enhancing the scope of such methods. Herein, meta-C–H allylation of arenes has been achieved with the aid of
a palladium catalyst, pyrimidine-based auxiliary, and allyl phosphate.
1,1,1,3,3,3-Hexafluoroisopropanol (HFIP) was found as a critical solvent
in this transformation. The role of HFIP throughout the catalytic
cycle has been systematically studied. A broad substrate scope with
phenethyl ether, phenol, benzylsulfonyl ester, phenethylsulfonyl ester,
phenylacetic acid, hydrocinnamic acid, and 2-phenylbenzoic acid derivatives
has been demonstrated. Interestingly, conformationally flexible arenes
have also been selectively allylated at the meta-position
using allyl phosphate. A combination of 1H NMR, 31P NMR, ESI-MS, kinetic experiments, and density functional theory
(DFT) computations suggested that reaction proceeds through a ligand-assisted meta-C–H activation, allyl addition forming a Pd-π-allyl
complex which is then followed by a turnover determining the C–C
bond formation step leading to the meta-allylated
product.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.